Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.

JCO Precis Oncol · 2024 · PMC11371111 · PMID 38986047

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < .001actually significant

32 The prognostic index was highly significant in the VG ( P < .001) and with a regression coefficient of 1.04 very close to the optimal value of 1, indicating no obvious bias or overfitting.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.